An international team of researchers conducts a study that defines a simple, low-cost blood test that yields high-performing results in the elimination of hepatitis C.
Liver Conditions & Procedures
A collaborative U-M team shows that liver injury is less likely to originate from popular cancer immunotherapy drug, pembrolizumab, than tumor progression.
U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.
An enzyme’s newly discovered ability to spur the body to prevent or repair acute liver injury in mice could be harnessed as a therapy or used as a biomarker.<
A recent paper from two U-M hepatologists highlights the liver dangers associated with consuming some herbal and dietary supplements designed to build muscle or lose weight.
A cutting-edge imaging strategy could significantly improve survival rates among patients at risk for liver cancer.